Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).

G Marrone,R Angelico,M Di Lauro, E Sargentini,T M Manzia,G Tisone,A P Mitterhofer,D Della Morte Canosci,M Tesauro,N Di Daniele,A Noce

European review for medical and pharmacological sciences（2023）

Cited 0|Views20

No score

Abstract

Considering the presence of an enzyme replacement therapy able to modify FD clinical history, it is essential to try to implement FD early diagnoses. However, the screening is too expensive to be extended on large scale, due to the low prevalence of the pathology. The screening should be performed on high-risk populations.

Translated text

Key words

Fabry disease, Renal replacement therapy, Kidney transplantation, End stage renal disease, Lysosomal storage disease, Alpha-galactosidase, Lyso-Gb3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined